Compare STGW & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | STGW | AORT |
|---|---|---|
| Founded | 1980 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.7B |
| IPO Year | 2006 | 1996 |
| Metric | STGW | AORT |
|---|---|---|
| Price | $6.62 | $34.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 5 |
| Target Price | $8.39 | ★ $49.40 |
| AVG Volume (30 Days) | ★ 1.2M | 367.0K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | ★ $2,909,000,000.00 | $298,836,000.00 |
| Revenue This Year | $13.27 | $14.20 |
| Revenue Next Year | $4.07 | $11.20 |
| P/E Ratio | ★ N/A | $171.57 |
| Revenue Growth | 2.39 | ★ 18.01 |
| 52 Week Low | $4.03 | $23.15 |
| 52 Week High | $7.52 | $48.25 |
| Indicator | STGW | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 53.21 | 40.21 |
| Support Level | $4.87 | $33.33 |
| Resistance Level | $7.02 | $38.02 |
| Average True Range (ATR) | 0.30 | 1.43 |
| MACD | -0.05 | -0.14 |
| Stochastic Oscillator | 37.23 | 7.29 |
Stagwell Inc is a challenger network using AI to deliver marketing and advertising solutions to its clients. It operates in five reportable segments: Marketing Services, Digital Transformation, Media and Commerce, Communications, and The Marketing Cloud. Maximum revenue is generated from the Marketing Services segment, which offers social media solutions, designs breakthrough brand campaigns, and creates immersive experiential marketing programs and social engagement strategies, helping clients connect with audiences across digital platforms. The various brands operating under this segment include 72 and Sunny, Anomaly, NRG, Harris Insights, TEAM, and Movers & Shaker. Geographically, the company generates maximum revenue from the United States, followed by the UK and other countries.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.